, and interleukin-1 (IL-1) appears to be an inducer (23).
We made biochemical and physiological studies of a2-macroglobulin (a2M) (5, 6, 8, 9, 10, 14, 17, 18 tumor tissues (18). It acts as a protease inhibitor mainly in the circulatory system rather than in the tissues (18). It also has immunomodulative activity, suppressing the lymphocyte blastogenesis induced by lectins (14). A rapid and marked increase of a2M in serum is caused by its increased de novo synthesis in the liver (6, 19) and by hepatocytes (8, 9). The synthesis of a2M is modulated by various components, including hormones and cellular factors (1, 4, 7, 8, 9) . Murine IL-1 stimulates the synthesis of a2M in rat hepatocytes (2). Recently, Bauer et al.
(1) and our group (8) have demonstrated that a culture supernatant of Kupffer cells has hepatocyte-stimulating activity that enhances the synthesis of a2M by rat hepatocytes. The role of glucocorticoid in the induction of a2M also has been investigated in vivo (1, 4, 7) and in vitro (1, 8) . Little, however, is known about the regulating step of the glucocorticoid at the gene level during the induction of a2M.
A2M cDNA has been cloned by Northemann et al. (16) and in our laboratory (5). Using our cDNA as a probe, we demonstrated that the induction of a2M synthesis is regulated in the pretranslational stage (5). Factors such as hormones and chemical mediators would affect any experimental results gained from an in vivo system; therefore, the study of a2M expression with a2M cDNA in an in vitro system that uses a hepatocyte culture should provide an appropriate technique with which to determine the molecular mechanisms that function in the synthesis of acute phase proteins in hepatocytes.
We now have confirmed previous reports by Bauer et al.
(1) and ourselves (8) that both glucocorticoid and a cellular factor (the Kupffer factor) are necessary for the induction of a2M. We also have shown a2M synthesis quantitatively through a radioimmunoassay that demonstrates the 100-fold induction of a2M in vitro. Such marked enhancement has not been reported previously (1, 8) in studies in which the immunoprecipitation of radiolabeled a2M was used to measure a2M. It provides quantitative evidence with which to explain the in vivo phenomenon of the increase in serum a2M. Moreover, we have demonstrated that glucocorticoid is essential for the induction of a2M synthesis by the Kupffer cell-derived factor at both the protein and mRNA levels. Glucocorticoid and the Kupffer factor affect the induction of a2M is in the pretranslational, probably the transcriptional, stage. isolated the total RNA from hepatocytes (stimulated by Dex, the Kupffer factor, or both) and measured the amount of a2M mRNA present by dot blot analysis. The concentration of a2M mRNA was increased approximately 125-fold by an addition of the Kupffer factor in the presence of Dex (Fig. 4) , but an addition of the Kupffer factor alone did not increase the mRNA. An addition of 1µM of Dex alone produced 8-to 16-fold enhancement. We concluded that the Dex and the Kupffer factor affect a2M induction in the pretranslational stage, possibly in the transcriptional phase.
DISCUSSION
Recent investigations have shown that the synthesis of acute phase proteins is elicited in liver by IL-1, a macrophage-derived cytokine (22, 23 (8) found that supernatants from LPS-stimulated Kupffer cells from rats show hepatocyte-stimulating activity by inducing a2M synthesis. Recombinant IL-1 also has been demonstrated to stimulate a2M synthesis by directly affecting hepatocytes (2). Co-culture experiments demonstrated that an addition of LPS to the hepatocyte culture medium stimulated the synthesis of a2M, which suggests a role for LPS. LPS, itself, did not, however, directly cause hepatocytes to begin a2M synthesis, rather it worked via the Kupffer cells by stimulating them to secrete a hepatocytestimulating factor into the culture medium.
Our study has provided quantitative evidence for a2M synthesis by hepatocytes upon stimulation with Dex, the Kupffer factor or both. When both Dex and the supernatant of Kupffer cells were added to the medium, cultured hepatocytes synthesized a2M that was 100-fold the value found for the control hepatocytes incubated without a combination of the Kupffer factor and Dex. This marked difference was not found when a2M synthesis was measured by the immunoprecipitation of radiolabeled a2M (1, 8) . Thus, we here have shown an important function of glucocorticoid and a cellular factor (the Kupffer factor) in the induction of a2M in vivo which shows that serum a2M increases more than 100-fold in the acute phase. 
